Zytiga nabs EMA approval for broad use; OTC drugmakers see sales spike on flu season;

@FiercePharma: Zytiga wins European approval for earlier use. FDA did the same in December. Could be big for Janssen/J&J. More | Follow @FiercePharma

 @AlisonBFierce: Widespread flu outbreak gives vaccine manufacturers a shot in the arm. News | Follow @AlisonBFierce

> European regulators approved a big expansion in the use of Johnson & Johnson's ($JNJ) prostate cancer pill Zytiga, following the FDA's similar approval last month. Report

> Makers of over-the-counter flu and cold remedies are benefiting from this year's unusually strong flu season. Report

> Novartis ($NVS) says a new late-stage trial found that its meningitis vaccine Bexsero delivered a protective immune response in infants with a three-dose regimen, with additional effect after a booster in toddlers. Report

> GlaxoSmithKline ($GSK) has drawn the ire of small suppliers with new 90-day payment terms, which the company says are consistent with its corporate peers. Report

> As Roche ($RHHBY) prepares to pull out of Nutley, NJ, it's receiving offers for the 119-acre property and working to find jobs for laid-off workers. Report

> Lundbeck recruited Bayer Healthcare's Barbara Jaszewski to be its senior VP of global product strategy and portfolio development. Report

> Astellas Pharma won European approval for its overactive bladder treatment, Betmiga. Report

Biotech News

 @FierceBiotech: Trending on FierceBiotech.com: $GSK pilots 6th drug to regulators in R&D offensive. More | Follow @FierceBiotech

@JohnCFierce: Activists cry havoc, let slip the dogs of war on AstraZeneca. News | Follow @JohnCFierce

@RyanMFierce: PatientsLikeMe tackles extremely rare genetic disease. Item | Follow @RyanMFierce

> Eisai's pivotal hopes for ovarian cancer drug dashed by PhIII flop. Story

> Aileron snags $12M to fuel first human study of 'stapled' peptide. Article

Medical Device News

 @FierceMedDev: Experts: Odds of device tax repeal close to zero. Item | Follow @FierceMedDev

@MarkHFierce: Covidien begins postapproval study for stroke treatment device. More | Follow @MarkHFierce

 @DamianFierce: Last thing from JPM13: Talking Chinese outsourcing with Vertex, Merck, MedImmune and WuXi. Story | Follow @DamianFierce

> J&J's other hip device lands it back in court. Story

Biotech IT News

> How 'open' will Big Pharma get to treat R&D ills? Item

> Computer game rewards players for shirking flu shots. Report

> Elsevier snaps up drug R&D software company. Article

> Illumina, Life Tech trumpet startup efforts in clinical genomics. News

CRO News

> Report: Indian drug-related trial deaths rose in 2012. Report

> goBalto inks deal with INC for trial software. Article

> Catalent breathes $20M into inhalant business. News

> GVK partners with Onconova on cancer drugs. Story

> Parexel chief named ACRO chairman. Item

And Finally... Stroke survivors with depression are four times more likely to die than those who aren't depressed. Report